Icecure Medical

Icecure Medical Dividend Coverage

Dividend Coverage Ratio of Icecure Medical (ICCM) as of Oct 27, 2026.

Dividend Coverage

-

Last updated:

Dividend Coverage Ratio of Icecure Medical is 2026 - . Dividend Coverage Ratio of Icecure Medical was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Icecure Medical Stock analysis

What does Icecure Medical do? Icecure Medical Ltd., based in Caesarea, Israel, is a commercial-stage medical device company specializing in cryoablation systems for tumor treatment. The company develops and markets liquid nitrogen-based technologies, including the ProSense single-probe system and the non-commercialized MultiSense multi-probe system, offering minimally invasive alternatives to surgery for tumors in breast, lung, kidney, and bone tissues. With 65 employees, it has been listed since February 2011. Icecure Medical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Icecure Medical stock

On Eulerpool you can find the complete historical development of Dividend Coverage Ratio Icecure Medical since 2006 – with annual values, charts, and detailed analysis.

The dividend coverage ratio measures how many times dividends can be covered by net income. Higher coverage suggests more sustainable dividend payments.

Dividend Coverage Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Coverage Ratio's Icecure Medical historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dividend — Icecure Medical

All Key Metrics — Icecure Medical